Back

Association of non-invasive liver fibrosis scores with incident cardiovascular disease: a 10-year cohort study

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Broad consequences of common cardiometabolic risk factors Scores ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Leila Bikdelu

Mashhad University of Medical Sciences, Mashhad (Iran (Islamic Republic of))

5 More presentations in this session

Presentation thumbnail
Sex-specific testosterone mismatch and cardiovascular outcomes: insights from UK biobank participants
Doctor K. Dongseon (Anyang-Si- Gyeonggi-Do, KR)
Abstract
Presentation thumbnail
Reduced right ventricular ejection fraction predicts incident heart failure and mortality in individuals without prevalent heart failure: a propensity score-matched UK Biobank analysis
Doctor M. Tokodi (Budapest, HU)
Abstract
Presentation thumbnail
Paradoxical association between low hepatic steatosis index and mortality in older patients with heart failure
Doctor T. Noda (Suita, JP)
Abstract
Presentation thumbnail
Characteristics, prevalence, and outcomes of patients at high risk of developing heart failure: a nationwide cohort study
Mr C. Gansted (Copenhagen, DK)
Abstract
Presentation thumbnail
MAF-5 score and cT1 for cardiovascular risk: evidence from UK Biobank
Doctor J. Yang (Shanghai, CN)
Abstract

Access the full session

Session thumbnail
Broad consequences of common cardiometabolic risk factors

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Predictability of noninvasive liver fibrosis score for cardiac events in patients with nonalcoholic fatty liver disease
26 August 2023
thumbnail
Congress Presentation
The association between visit-to-visit variability in established risk factors and incident CVD: a post-hoc analysis of the multi-ethnic study of atherosclerosis
5 April 2025
thumbnail
Congress Presentation
Effectiveness of liver function tests in screening for cardiovascular risk in rheumatoid and psoriatic arthritis patients
12 December 2024
thumbnail
Congress Presentation
Can coronary inflammation and ai-risk scores from cardiovascular ct impact management in those with no conventional evidence of coronary artery disease?
3 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources